Trump vs Harvard, Nvidia export controls, how DEI killed Hollywood with Tim Dillon
Speakers
David Sacks
— General Partner, Craft Ventures
Chamath Palihapitiya
— CEO, Social Capital
David Friedberg
— CEO, The Production Board
Jason Calacanis
— Angel Investor / Founder, LAUNCH
Tim Dillon
— Comedian and host of The Tim Dillon Show
Summary
The All-In hosts welcome comedian Tim Dillon for an episode led by the new US export restriction on Nvidia's H20 chip to China. David Sacks defends the restriction on technical grounds and calls for fewer loopholes and tougher enforcement, Chamath Palihapitiya argues roughly 47% of Nvidia's revenue is China-linked and flows through shell-company way stations, and David Friedberg counters that China will build its own EUV and chip manufacturing capacity either way. The rest of the show covers the administration's funding and tax-exempt fight with Harvard, university research overhead and meritocracy, Hollywood's DEI era, and a science segment on mitochondrial therapy.
- The White House placed an indefinite export restriction on Nvidia's H20 chip to China; Nvidia flagged a $5.5 billion quarterly charge and the stock fell about 6%.
- David Sacks: the H20 has roughly 20% more memory bandwidth than the H100, which matters more than flops in the reinforcement-learning era, so the chip is too capable to sell to China.
- Sacks wants the boundary lines redrawn with fewer loopholes plus more monitoring, inspection and enforcement, and says the Commerce Department's BIS agency is understaffed for the task.
- Chamath: about 47% of Nvidia revenue goes to China and China-related countries, and front companies in Singapore, Vietnam, Cambodia and similar markets act as way stations into the mainland.
- Friedberg: China's $37 billion domestic chip program, SMIC's 7-nanometer Huawei chip and claimed EUV progress mean China builds its own capacity either way.
- Sacks frames ASML's sole-supplier position in EUV lithography as the real chokepoint, and the 2019 ban on those machines as the far-sighted decision.
- Harvard segment: $2.2 billion in grants frozen and tax-exempt status under review; the hosts debate the Bob Jones precedent, DEI in admissions and hiring, the $53.2 billion endowment and 69% NIH overhead.
- Tim Dillon argues Hollywood's DEI push was never profitable and executives reverted to viewership and the profit motive; Friedberg closes with three papers pointing toward mitochondrial therapy.
Ideas
ASML monopoly is the China chokepoint.
Sacks frames extreme ultraviolet lithography as the single chokepoint of the whole chip war: it is the key technology for printing transistors on the silicon wafer, the machines cost around $200 million each, and only one company in the world makes them - ASML in the Netherlands. He credits the first Trump administration's 2019 ban on EUV equipment going to China as a far-sighted decision, arguing that without it China might today be dominating global semiconductor manufacturing, and that being cut off from this equipment definitely put a dent in their plans. The decision-useful point is that ASML's sole-supplier position on the tool, rather than any individual chip, is what sets the ceiling on Chinese manufacturing capability and is the lever US policy actually pulls.
H20 too capable; China curbs tighten.
Sacks argues the indefinite ban on Nvidia's H20 going to China is justified on the merits. The H20 was engineered as a Nerf version of the H100 with flops cut just under the export-control threshold, but flops are no longer the only measure of a chip: in the reinforcement-learning and test-time-compute paradigm memory bandwidth matters more, and the H20 actually carries about 20% more memory bandwidth than the H100, so the chip is frankly too good to hand to China. He supports export controls in principle - he would not sell China a GB200 at any price, at some point a technology is simply too sensitive - and says the current regime leaks badly: boundary lines have to be redrawn with fewer loopholes companies can legally exploit, and the BIS agency inside the Commerce Department is understaffed for the monitoring, inspection and enforcement this requires. The investment-relevant consequence is that Nvidia's China-facing product line keeps getting closed off one chip at a time while enforcement risk rises.
China builds domestic chip capacity anyway.
Friedberg argues export controls will not stop China from building its own semiconductor stack. Beijing announced and began a $37 billion investment in domestic 3-nanometer chip technology last year, SMIC already launched a 7-nanometer chip with Huawei in the Mate 60 Pro, and China claims to have developed its own EUV system - which, as he concedes, looks like heavy reverse engineering and workarounds of existing technology for now. His conclusion is that China is going to invest in and build its own EUV and chip manufacturing capacity either way; the only open question is whether US controls slow them down at the application or AI layer. That makes SMIC the vehicle of a state-backed domestic capacity build that proceeds regardless of which way the policy goes.
Half of Nvidia revenue is China-linked.
Chamath's claim is that Nvidia has worked around the guidelines at every turn - the A800 and H800 after the A100/H100 ban, then the purpose-built H20 - while China has been methodically executing its 2017 State Council plan to occupy the commanding heights of AI by 2030. He puts up Nvidia's revenue composition and says roughly 47% of all Nvidia revenue goes to China and China-related countries, then argues it is implausible that Singapore, Vietnam, Taiwan, Cambodia or Bhutan host applications needing that much AI horsepower: there is no Cursor of Bhutan. His read is that shell entities present clean purchase orders of $300-800 million, Nvidia takes the order and looks away, and the chips are then used by Chinese organizations - which is why Alibaba and DeepSeek keep matching US advances. If Washington does one or two layers of tracing and enforces, a large part of that revenue base is exposed.
Up Next
This All-In Podcast video, published April 19, 2025, features David Sacks, David Friedberg, Chamath Palihapitiya discussing ASML, NVDA, 0981.HK. 4 trade ideas extracted by AI with direction and confidence scoring.
Speakers: David Sacks, David Friedberg, Chamath Palihapitiya · Tickers: ASML, NVDA, 0981.HK